Chemical Safety for Sustainability & Health and Environmental Risk Assessment Subcommittee
EPA's Chemical Safety for Sustainability research program provides the decision-support tools needed to meet that priority, while advancing innovative ways to evaluate chemicals, conduct risk management, and prioritize time-critical research.
Using innovative approaches, EPA scientists and their partners are embracing the principles of green chemistry to produce safer chemicals. They are also integrating a diversity of scientific disciplines to develop new prediction techniques, pioneering the use of innovative technologies for chemical toxicity testing, and designing tools to advance the management of chemical risks. Chemical safety for sustainability includes research in computational toxicology, nanotechnology, endocrine disrupting chemicals, human health, and pesticides.
- Learn more about the Chemical Safety for Sustainability Research Program
- View the FY19-22 CSS Strategic Research Action Plan
Featured Research and Tools:
· Per- and Polyfluoroalkyl Substances (PFAS)
· Overview of ToxCast, Tox21, and EPA’s computational toxicology tools
The Health and Environmental Risk Assessment (HERA) Program at EPA is focused on advancing the understanding of the effects that exposure to pollutants have on key biological, chemical, and physical processes that affect human health. What EPA scientists and their partners learn provides the foundation for the Agency’s actions to protect public health and the environment.
Featured Research and Tools:
· Human Health Risk Assessment Guidelines
Subcommittee Members
Chair
Katrina Waters, PhD
Division Director, Biological Sciences
Pacific Northwest National Laboratory
Vice Chair
James Stevens, PhD
President
Paradox Found LLC
Members
Anthony Bahinski, PhD, MBA,
FAHA
Global Head, Safety Pharmacology
GlaxoSmithKline
Juan Colberg, PhD
Sr. Director of Chemical
Technology & Innovation and
Pfizer Green Chemistry Program
Leader
Pfizer Inc. Worldwide Research
& Development
Chris Gennings, PhD
Research Professor
Icahn School of Medicine at
Mount Sinai
Daland Juberg, PhD, MS
Global Leader, Human Health
Assessment
Dow AgroSciences LLC
Timothy Malloy, JD
Professor
University of California,
Los Angeles
Jane Rose, PhD
Principal Scientist
Procter & Gamble Co.
Ponisseril Somasundaran,
PhD, MS
La von Duddleson Krumb
Professor; President
Columbia University;
Somasundaran, Inc
Cliff Weisel, PhD
Professor, Exposure Science,
Environmental and
Occupational
Health Sciences Institute
Rutgers University
Richard Becker, PhD, DABT
Senior Toxicologist
American Chemistry Council
Richard DiGiulio, Ph. D., MS
Professor
Duke University
Dale Johnson, PhD, PharmD,
DABT
Adjunct Professor;
University of California, Berkeley;
President & CEO
Emiliem Inc.
Juleen Lam, PhD, MHS, MS
Assistant Professor
California State University, East Bay
Jennifer McPartland, PhD
Senior Scientist
Environmental Defense Fund
Gina Solomon, MD, MPH
Principal Investigator
Public Health Institute
Donna Vorhees, Sc.D.
Director of Energy Research;
Adjunct Assistant Professor
Health Effects Institute;
Boston University
Mark Wiesner, PhD
James L. Meriam Professor of
Civil & Environmental
Engineering, Director,
Center for the
Environmental Implications of
NanoTechnology (CEINT)
Duke University
Designated Federal Official (DFO)
Tom Tracy (tracy.tom@epa.gov)
Office of Science Advisor, Policy and Engagement
Office of Research and Development
U.S. EPA